NCT01587352 2026-03-18Vorinostat in Treating Patients With Metastatic Melanoma of the EyeNational Cancer Institute (NCI)Phase 2 Active not recruiting40 enrolled
NCT03022565 2020-02-06Vorinostat in Patients With Class 2 High Risk Uveal MelanomaUniversity of MiamiPhase EARLY_PHASE1 Withdrawn
NCT00121225 2019-01-29Vorinostat in Treating Patients With Metastatic or Unresectable MelanomaNational Cancer Institute (NCI)Phase 2 Completed32 enrolled 11 charts